| Authors: |
Burton EM; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX., Milton DR; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX., Tetzlaff MT; Department of Pathology, The University of California San Francisco, San Francisco, CA., Wani K; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Ross MI; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Postow MA; Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY., Lazcano R; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Glitza IC; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Wong MK; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Patel SP; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.; University of Colorado Cancer Center, Aurora, CO., Diab A; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Gershenwald JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., McQuade JL; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Betof Warner A; Stanford University School of Medicine, Stanford University, Stanford, CA., Prieto VG; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Lee JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Goepfert RP; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX., Fisher SB; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Song A; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Malke J; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Simon JM; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Ariyan C; Department of Surgical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Torres-Cabala CA; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Davies MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Lazar A; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Wargo JA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Tawbi HA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Amaria RN; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. |